Stock Scorecard
Stock Summary for Abbvie Inc (ABBV) - $190.76 as of 5/13/2025 8:40:09 AM EST
Total Score
8 out of 30
Safety Score
64 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ABBV
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ABBV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ABBV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ABBV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ABBV (64 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ABBV
Financial Details for ABBV
Company Overview |
|
|---|---|
| Ticker | ABBV |
| Company Name | Abbvie Inc |
| Country | USA |
| Description | AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/23/2025 |
Stock Price History |
|
| Last Day Price | 190.76 |
| Price 4 Years Ago | 118.52 |
| Last Day Price Updated | 5/13/2025 8:40:09 AM EST |
| Last Day Volume | 7,806,372 |
| Average Daily Volume | 9,247,428 |
| 52-Week High | 216.66 |
| 52-Week Low | 148.19 |
| Last Price to 52 Week Low | 28.73% |
Valuation Measures |
|
| Trailing PE | 78.89 |
| Industry PE | 30.10 |
| Sector PE | 47.92 |
| 5-Year Average PE | 26.95 |
| Free Cash Flow Ratio | 61.14 |
| Industry Free Cash Flow Ratio | 18.49 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 0.66 |
| Total Cash Per Share | 3.12 |
| Book Value Per Share Most Recent Quarter | 1.88 |
| Price to Book Ratio | 229.63 |
| Industry Price to Book Ratio | 35.42 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 5.69 |
| Industry Price to Sales Ratio Twelve Trailing Months | 89.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | 13 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 1,768,980,000 |
| Market Capitalization | 337,450,624,800 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/15/2025 |
| Previous Dividend Amount | 1.6400 |
| Current Dividend Amount | 1.6400 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 6.38 |
| Trailing Annual Dividend Yield | 3.45% |
| Forward Annual Dividend Rate | 6.56 |
| Forward Annual Dividend Yield | 3.55% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.56% |
| 5-Year Average Dividend Yield | 3.95% |
| 1-Year Dividend Growth Rate Percentage | 5.81% |
| 3-Year Dividend Growth Rate Percentage | 2.86% |
| 5-Year Dividend Growth Rate Percentage | 5.98% |
| All-Time Dividend Growth Rate Percentage | 13.10% |
| Dividend Payout Ratio | 272.65% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -6.30% |
| Annual Earnings Growth | -12.03% |
| Reported EPS 12 Trailing Months | 2.34 |
| Reported EPS Past Year | 2.46 |
| Reported EPS Prior Year | 10.12 |
| Net Income Twelve Trailing Months | 4,195,000,000 |
| Net Income Past Year | 4,278,000,000 |
| Net Income Prior Year | 4,863,000,000 |
| Quarterly Revenue Growth YOY | 8.40% |
| 5-Year Revenue Growth | 11.11% |
| Operating Margin Twelve Trailing Months | 29.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 5,524,000,000 |
| Total Cash Past Year | 5,524,000,000 |
| Total Cash Prior Year | 12,814,000,000 |
| Net Cash Position Most Recent Quarter | -54,816,000,000 |
| Net Cash Position Past Year | -54,816,000,000 |
| Long Term Debt Past Year | 60,340,000,000 |
| Long Term Debt Prior Year | 52,194,000,000 |
| Total Debt Most Recent Quarter | 60,340,000,000 |
| Equity to Debt Ratio Past Year | 0.05 |
| Equity to Debt Ratio Most Recent Quarter | 0.05 |
| Total Stockholder Equity Past Year | 3,325,000,000 |
| Total Stockholder Equity Prior Year | 10,360,000,000 |
| Total Stockholder Equity Most Recent Quarter | 3,325,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 17,832,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 10.08 |
| Free Cash Flow Past Year | 17,832,000,000 |
| Free Cash Flow Prior Year | 22,062,000,000 |
Options |
|
| Put/Call Ratio | 1.75 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.91 |
| MACD Signal | -1.09 |
| 20-Day Bollinger Lower Band | 161.29 |
| 20-Day Bollinger Middle Band | 189.12 |
| 20-Day Bollinger Upper Band | 216.96 |
| Beta | 0.55 |
| RSI | 42.20 |
| 50-Day SMA | 181.80 |
| 150-Day SMA | 155.29 |
| 200-Day SMA | 145.66 |
System |
|
| Modified | 5/12/2025 4:17:51 PM EST |